A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2002
12/11/2002	EP1263469A1 Compositions and methods for enhancing drug delivery across biological membranes and tissues
12/11/2002	EP1263468A1 Formulation solubilizing water-insoluble agents and preparation method thereof
12/11/2002	EP1263465A2 Photodynamic cellular and acellular organism eradication using a photosensitive material and surfactant
12/11/2002	EP1263464A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function
12/11/2002	EP1263462A1 Human herpesvirus 6a and 6b transfer factors for the treatment of chronic fatigue syndrome and multiple sclerosis
12/11/2002	EP1263460A1 Pharmaceutical carrier composition for papayne based products
12/11/2002	EP1263459A2 Attenuation of fibroblast proliferation
12/11/2002	EP1263458A1 Lowering serum lipids
12/11/2002	EP1263457A2 Hiv immune adjuvant therapy
12/11/2002	EP1263456A2 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia"
12/11/2002	EP1263455A2 Uses of bombesin receptor 3
12/11/2002	EP1263454A2 Methods for enhancing the bioavailability of a drug
12/11/2002	EP1263453A2 Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix
12/11/2002	EP1263452A2 Methods and compositions for generating angiostatin
12/11/2002	EP1263446A2 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
12/11/2002	EP1263436A1 Use of glucosylceramide synthesis inhibitors in brain cancertherapy
12/11/2002	EP1263428A2 Free radical scavengers for the treatment of premature birth
12/11/2002	EP1263419A2 Compounds capable of binding with the cytoskeleton
12/11/2002	EP1263365A1 Malleable paste with allograft bone reinforcement for filling bone defects
12/11/2002	EP1263297A1 Diabetic nutritionals
12/11/2002	EP1148791B1 Protein material for slow digestion and its use
12/11/2002	EP1140986B1 Pseudopeptide, synthesis method, reagent and applications
12/11/2002	EP1071433B1 2',2'-difluoronucleosides for immunosuppressive therapy and combined pharmaceutical compositions
12/11/2002	EP0981521B1 Novel macrocyclic compounds as metalloprotease inhibitors
12/11/2002	EP0971728B1 Use of interleukin-15
12/11/2002	EP0942741B1 Lectin compositions and uses thereof
12/11/2002	EP0859630B1 Combination of temozolomide and alpha-ifn for the treatment of advanced cancer
12/11/2002	EP0831871B1 Relaxin-like factor and methods and uses thereof
12/11/2002	EP0820289B1 Trapidil for use in the treatment of immuno-modulatorily influencible cases
12/11/2002	EP0807185B9 Antitumor preparations containing a lipoteichoic acid from steptococcus
12/11/2002	EP0802985B1 Cell cycle regulated repressor and dna element
12/11/2002	EP0788511B1 Cyclic hexapeptides having antibiotic activity
12/11/2002	EP0754052B1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound
12/11/2002	CN1384878A IREN protein, its preparation and use
12/11/2002	CN1384876A Modular transport systems for molecular substances and production and use thereof
12/11/2002	CN1384840A Antibody of human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin
12/11/2002	CN1384814A Phenoxy carboxylic acid compounds and compositions for delivering active agents
12/11/2002	CN1384758A Mutant human CD80 and copositions for and methods of making and using the same
12/11/2002	CN1384757A Method for down-regulating GDF-8 activity
12/11/2002	CN1384755A Novel exendin agonist formulations and methods administration thereof
12/11/2002	CN1384754A Method and composition for treating prostate cancer
12/11/2002	CN1384753A Pharmaceutical agent preparations
12/11/2002	CN1384752A Remedies for nervous diseases
12/11/2002	CN1384734A Surface modified particulate compositions of biologically active substances
12/11/2002	CN1384733A Dry powder compositions having improved dispersivity
12/11/2002	CN1384707A Preserving hemoglobin blood substitute with transparent overwrap
12/11/2002	CN1384201A Blood sugar reducing method of orally taking human insulin-like growth factor-I produced in silkworm bioreactor
12/11/2002	CN1384116A New-type alpha-interferon
12/11/2002	CN1384114A Growth promoting factor and its prepn and use
12/11/2002	CN1384112A High-efficient production process of genetically engineered medicine Angel thrombus-resisting factor
12/11/2002	CN1383894A Chinese and western combined medicine for treating chronic enterogastritis and ulcer and its prepn
12/11/2002	CN1383893A Genetically engineerined silkworm's phytase prepn with high enzyme activity
12/11/2002	CN1383892A Eye medicament
12/11/2002	CN1383891A Life-proloning peptide health food
12/11/2002	CN1383887A Antisenility medicine composition and its prepn
12/11/2002	CA2350005A1 Topical wound therapeutic compositions
12/10/2002	USRE37933 Locally administering to mammalian vascular smooth muscle cells replication defective recombinant adenovirus comprising gene encoding mammalian gax protein, wherein gene is expressed and proliferation of cells is inhibited
12/10/2002	US6493637 Coincidence detection method, products and apparatus
12/10/2002	US6492553 A method for preparing a n-((aliphatic or aromatic)carbonyl) )-2-aminoacetamide compound, and for preparing a cyclized compound therefrom, as well as novel resin bound intermediate compounds that are useful for preparing such compounds.
12/10/2002	US6492507 Polynucleotides encoding human eosinophil-derived basic protein
12/10/2002	US6492504 Nucleotide sequence of mammastatin and methods of use
12/10/2002	US6492499 Human pancreatitis-associated protein
12/10/2002	US6492496 Antibodies to the receptor protein designated 2F1
12/10/2002	US6492495 PTP-S31: a novel protein tyrosine phosphatase
12/10/2002	US6492494 Method of making a fibrin sealant comprising alpha-2-antiplasmin
12/10/2002	US6492493 Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
12/10/2002	US6492490 Liquid phase peptide syntheses of KL-4 pulmonary surfactant
12/10/2002	US6492428 Macrophage migration inhibitory factor (mif); substituted iminoquinone or orthoquinone ring systems
12/10/2002	US6492412 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
12/10/2002	US6492402 Anticoagulants; peptide derivatives having high antithrombotic activity and oral bioavailability
12/10/2002	US6492372 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
12/10/2002	US6492365 Microsomal triglyceride transfer protein
12/10/2002	US6492335 Glycoconjugates from modified camptothecin derivatives (20-O-linkage)
12/10/2002	US6492333 Treatment of myeloma bone disease with proteasomal and NF-κB activity inhibitors
12/10/2002	US6492332 Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation
12/10/2002	US6492331 NL8 tie ligands homologues
12/10/2002	US6492330 Antiangiogenic drugs
12/10/2002	US6492329 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
12/10/2002	US6492328 Activity against gram-negative bacteria
12/10/2002	US6492327 Isolation of purified TGF- β1 and TGF -β2 from bone tissue
12/10/2002	US6492326 Containing a pentapeptide
12/10/2002	US6492325 Use of α1β1 integrin receptor inhibitors and TGF-β1 inhibitors in the treatment of kidney disease
12/10/2002	US6492324 APJ ligand polypeptides
12/10/2002	US6492177 Kit for use in treatment of polycystic ovarian disease
12/10/2002	US6492173 Anticarcinogenic agents
12/10/2002	US6492172 Antisense modulation of GU protein expression
12/10/2002	US6492171 Antisense modulation of TERT expression
12/10/2002	US6492170 Antisense modulation of caspase 9 expression
12/10/2002	US6492167 Membrane protein for use in the treatnment of diabetes, hypotension, endocrine defects
12/10/2002	US6492157 Methods are provided for the treatment of conditions associated with cells proliferation, cells differentiation and cell survival. in particular, the dual-specificity phosphatase dsp-9, and polypeptide variants thereof that
12/10/2002	US6492154 Genetic engineering
12/10/2002	US6492153 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
12/10/2002	US6492150 An isolated and purified dna molecule encoding hyaluronan synthase-2 (has2) is provided, as is purified and isolated has2 polypeptide.
12/10/2002	US6492140 Polynucleotides encoding cytokine designated LERK-5
12/10/2002	US6492131 Class I-type lysyl-TRNA synthetase
12/10/2002	US6492129 Fragments comprising the n-terminal region of connective tissue growth factor (ctgf); screening for inhibitors or stimulators of ctgf
12/10/2002	US6492126 Compositions and methods for the treatment and diagnosis of cardiovascular disease
12/10/2002	US6492123 Polypeptides comprising a first domain of an immunoglobulin heavy chain variable region, and a second domain of an immunoglobulin light chain variable region, linked but incapable of associating with each other; assay for antigen
12/10/2002	US6492112 Mitogen-activated protein kinase kinase 7 (MKK7)
12/10/2002	US6492111 Oligonucleotides identiphores are caused to bind specifically to target nucleic acid which is predictive of a disease state such as cancer within cells, and are detected by spectrum analysis

1 ... 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 ... 3163